A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects

NCT06033742 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HS-10374 tablets
DRUG: HS-10374-matched placebo tablets

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.